CHD9 and osteosarcoma: GR occupancy was assessed by ChIP-seq experiments with GR antibody, using U2OS-GRα osteosarcoma cells transfected with six different siRNA combinations: non-specific siRNA control (siNS/siNS), depletion of Hic-5 (siHic5/siNS), depletion of CHD9 (siCHD9/siNS), double depletion of Hic-5 and CHD9 (siCHD9/siHic5), depletion of BRM (siBRM/siNS), and double depletion of Hic-5 and BRM (siBRM/siHic5).